跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUPKYNIS 7,9 MG CAPSULAS BLANDAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LUPKYNIS 7,9 MG CAPSULAS BLANDAS
Approved
STANDARD
LUPKYNIS 7,9 MG CAPSULAS BLANDAS
Otsuka Pharmaceutical Netherlands B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 27, 2022
Approval ID
af84d6de7db6278e
Company
Otsuka Pharmaceutical Netherlands B.V.
Type
Standard
Approval Details
Approval Id
af84d6de7db6278e
Drug Cima Aemps Name
LUPKYNIS 7,9 MG CAPSULAS BLANDAS
Register Number
1221678001
Holder Company Name
Otsuka Pharmaceutical Netherlands B.V.
Marketing Company Name
Otsuka Pharmaceutical S.A.
Holder Company Detail Path
/organization/otsuka-pharmaceutical-netherlands-b-v
Authorization Date
2022-09-27
Dosage Form
CÁPSULA BLANDA
Dose
7,9 MG
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Otsuka Pharmaceutical Netherlands B.V.
Company Detail Path
/organization/otsuka-pharmaceutical-netherlands-b-v
Company Information
Pharmaceutical Company Name
Otsuka Pharmaceutical Netherlands B.V.
Country Name
Netherlands
Active Ingredients
VOCLOSPORINA
7,9 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 27, 2022
Approval ID
af84d6de7db6278e
Type
Standard
Back to CIMA-AEMPS Approvals